ConvaTec Group PLC Director/PDMR Shareholding (5179C)

TIDMCTEC

RNS Number : 5179C

ConvaTec Group PLC

19 October 2020

19 October 2020

ConvaTec Group Plc

("ConvaTec" or "the Company")

Director/PDMR Shareholding

The Company has been notified of the following transaction by a Person Discharging Managerial Responsibility ("PDMR") in ordinary shares of 10 pence each in the share capital of the Company ("Shares").

On 15 October 2020, Mr Rick Anderson, Non-Executive Director and a PDMR, acquired 547 Shares at GBP1.8628 per share under the Scrip Dividend Scheme. Mr Anderson's resulting shareholding is 209,137 Shares.

The attached notification, made in accordance with the requirements of the EU Market Abuse Regulation, gives further detail.

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 
  1      Details of the person discharging managerial responsibilities/person 
          closely associated 
  a)    Name                                              Rick Anderson 
  2     Reason for the notification 
  a)    Position/Status                                   Non-Executive Director 
  b)    Initial notification/Amendment                    Initial notification 
  3     Details of the issuer, emission allowance market participant, 
         auction platform, auctioneer or auction monitor 
  a)    Name                                              ConvaTec Group Plc 
  b)    LEI                                               213800LS272L4FIDOH92 
  4     Details of the transaction(s): section to be repeated for 
         (i) each type of instrument; (ii) each type of transaction; 
         (iii) each date; and (iv) each place where transactions have 
         been conducted 
  a)    Description of the financial                      Ordinary shares of 10p each in ConvaTec Group Plc ("Shares") 
         instrument, type of instrument                    GB00BD3VFW73 
         Identification code 
  b)    Nature of the transaction                          Acquisition of Shares under Scrip Dividend Scheme 
  c)    Price(s) and volume(s)                            Price(s)                                         Volume(s) 
                                                           GBP1.8628                                        547 
  d)    Aggregated information 
         - Aggregated volume                                N/A 
         - Price                                            N/A 
  e)    Date of the transaction                           15 October 2020 
  f)    Place of the transaction                          Outside a trading venue 
 
 

Enquiries

Analysts and Investors

Kate Postans, VP Investor Relations &

   Corporate Communications, ConvaTec                                    [phone] 

[e-mail]

Media

   Buchanan: Charles Ryland / Chris Lane                                   [phone] 

ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92

About ConvaTec

ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion care. Our vision, which encompasses our purpose, is: Pioneering trusted medical solutions to improve the lives we touch. Our products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com .

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHFLFLSIRLALII

(END) Dow Jones Newswires

October 19, 2020 10:30 ET (14:30 GMT)